Results 251 to 260 of about 776,387 (309)

Liquid Metal Nanotransformers for Drug‐Resistant Pan‐Cancer Therapy in Patient‐Derived Organoids

Advanced Science, EarlyView.
Pan‐cancer therapies are severely limited in drug‐resistance patients due to genetic mutations and other factors, resulting in poor therapeutic outcomes and constrained clinical benefit. Liquid metal nanotransformers, a new class of shape‐transformable nanomaterials capable of dramatic morphological changes, offer a promising physical strategy to ...
Xiaojie Yuan, Xuelin Wang, Zhongyao Chen, Shuo Wang, Weining Gao, Ziyi Chen, Runyang Li, Cheng Hao, Lei Zhang, Qiongqiong Zhang, Ke Zhang, Mei Yu, Qian Liu, Jingxuan Wang, Huiping Li, Simpkins Fiona, Jing Liu, Qiang Liu, Peng Liu, Yawei Hu   +19 more
wiley   +1 more source

The hsa_circ_0070354/miR-4322/RAB3B Axis Facilitates the Carcinogenesis and Development of Non-Small Cell Lung Cancer (NSCLC). [PDF]

Cancer Med
Huang Y, Qin S, Zhang Y, Gu X, Zheng M, Ling G, Yang L, Ju S.   +7 more
europepmc   +1 more source

Bioprinted Tumor Microenvironment Models Reveal Immune Evasion and Guide CAR‐NK Therapeutic Strategies

Advanced Science, EarlyView.
This study presents a 3D embedded bioprinting platform that recapitulates key stromal features of the tumor microenvironment using fibroblasts and lung‐derived ECM. The model enables functional assessment of CAR‐NK cells and provides a versatile tool to support the development of next‐generation immunotherapeutic strategies against solid tumors ...
Dahong Kim, Seona Jo, In‐Hwan Jang, Yu‐Jin Kim, Youngmee Jung, Junhyoung Ahn, Hyungjun Lim, Jae Jong Lee, Kangwon Lee, Tae‐Don Kim, Su A Park   +10 more
wiley   +1 more source

Non-Small-Cell Lung Cancer: From Histopathological Classification to Precision Oncology-A Narrative Review. [PDF]

J Clin Med
Roșu SM, Biciușcă V, Stan SI, Mitroi DM, Mahler B, Trașcă DM, Popescu M, Pădureanu MM, Stoica AȘ, Pencea TI, Croitoru IA, Bălteanu MA.   +11 more
europepmc   +1 more source

Real-world trends in diagnosis, treatment, and survival of non-small cell lung cancer in Vietnam. [PDF]

BMC Cancer
Pham VH, Duong DC, Nguyen VB, Do HN, Nguyen KT, Nguyen TTM, Pham TH, Ngo VL, Nguyen VT, Ho MD, Truong KH, Ho BD, Nguyen VN.   +12 more
europepmc   +1 more source

BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCER. [PDF]

Cancer Discov
Schroeder BA, Mohindroo C, Meinhardt AL, Takahashi N, Zhang Y, Lee MJ, Sahoo S, Donahue RN, Kumar R, Nirula M, Yang Y, Rastogi S, Sato N, Lee S, Tsai YT, Zhuang S, Kazi A, Huang Y, Desai P, Nichols S, Sciuto L, Pinkiert D, Chrisafis G, Greenberg M, Biery DN, Al-Marayaty R, Yang HH, Lee MP, Schultz CW, El Meskini R, Atkinson D, Fousek K, Gulley JL, Schlom J, Sato M, Shrestha RL, Sharma AK, Jolly MK, Palena C, Wakefield LM, Thomas A.   +40 more
europepmc   +1 more source

Entrectinib-Induced Sinus Bradycardia in a Patient With Metastatic Non-Small Cell Lung Cancer. [PDF]

JACC Case Rep
Talasaz AH, Goldberg AJ, Shu CA, Sayer GT, Uriel N, Raikhelkar JK.   +5 more
europepmc   +1 more source

Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. [PDF]

Sci Adv
Luvisotto A, Tulaiha R, Wang L.
europepmc   +1 more source

Radiomics to understand pre-treatment tumor biology for resectable non-small cell lung cancer. [PDF]

Front Oncol
Zollinger B, Pham D, Suzuki K.
europepmc   +1 more source